(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Ascites

(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium has been researched along with Ascites in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, D; Berek, JS; Dorigo, O; Hernandez, P; Horton, HM; Parker, SE	1

Other Studies

1 other study(ies) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Ascites

Article	Year
IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile. Journal of immunology (Baltimore, Md. : 1950), 1999, Dec-15, Volume: 163, Issue:12 Topics: Animals; Antineoplastic Agents; Ascites; Cytokines; DNA, Bacterial; Dose-Response Relationship, Immunologic; Female; Growth Inhibitors; Injections, Intraperitoneal; Interleukin-2; Lipids; Mice; Mice, Inbred C3H; Mice, Nude; Ovarian Neoplasms; Phosphatidylethanolamines; Plasmids; Quaternary Ammonium Compounds; Teratocarcinoma	1999

Article

Year

IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile.

Journal of immunology (Baltimore, Md. : 1950), 1999, Dec-15, Volume: 163, Issue:12

Topics: Animals; Antineoplastic Agents; Ascites; Cytokines; DNA, Bacterial; Dose-Response Relationship, Immunologic; Female; Growth Inhibitors; Injections, Intraperitoneal; Interleukin-2; Lipids; Mice; Mice, Inbred C3H; Mice, Nude; Ovarian Neoplasms; Phosphatidylethanolamines; Plasmids; Quaternary Ammonium Compounds; Teratocarcinoma

1999